3billion, Inc.
Research 3billion, Inc. (394800.KQ) on Bullrun: market cap KRW 167.70B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker394800.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 167.70B
- Financial periodQ2 2026
- RevenueKRW 3.79B
- Net incomeKRW 6.72B
- Free cash flow-KRW 2.55B
- Gross margin100.0%
Valuation Snapshot
latest market cap is KRW 167.70B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 167.70B | n/a | n/a | n/a |
Dividend history
About 3billion, Inc.
3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is 3billion, Inc.'s market cap?
3billion, Inc.'s market capitalization is KRW 167.70B.
What does 3billion, Inc. do?
3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers. The company was founded in 2016 and is based in Seoul, South Korea.